Simultaneous reduction of flow and fraction of inspired oxygen (FiO(2)) versus reduction of flow first or FiO(2) first in patients ready to be weaned from high-flow nasal cannula oxygen therapy: study protocol for a randomized controlled trial (SLOWH trial)

BACKGROUND: High-flow nasal cannula (HFNC) oxygen therapy has been widely used in critically ill patients. Despite the effectiveness of HFNC as a treatment, optimal methods to withdraw HFNC after recovery from preexisting conditions have not been investigated to date. In this study, we will evaluate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Trials
Autores principales: Kim, Min Chul, Lee, Yeon Joo, Park, Jong Sun, Cho, Young-Jae, Yoon, Ho Il, Lee, Choon-Taek, Lee, Jae Ho, Kim, Eun Sun
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961313/
https://ncbi.nlm.nih.gov/pubmed/31937322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-4019-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares